Apexigen
meaningful data in esophageal study of combination ongoing | Apexigen
Company
Deck Type
Sector
Industry
Deck date
March 2022
Slide
15 of 28
Similar slides by Apexigen
See diffirences between slides (animation)
Investor Presentation
September 2022
phase higher rates for standard of care soc | Apexigen
Related slides by other companies
ATAI
Investor Presentation
January 2024
compass pathways is currently conducting a phase pivotal program with topline data expected in summer and mid proceeded by long target | ATAI
ATAI
Investor Presentation
October 2023
compass pathways is currently conducting a phase pivotal program with topline data expected in summer and mid proceeded by long target | ATAI
DraftKings
SPAC
March 2020
case study personalized push notification sends right message to right user at right time a an on tiles a an | DraftKings
NeuroSense Therapeutics
Investor Presentation
October 2024
phase a data demonstrated reduced and levels in als patients treated with | NeuroSense Therapeutics
Other recent decks by Apexigen
See all presentations (2 decks)
Investor Presentation
September 2022
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights

Stay in the loop

Join our mailing list to stay in the loop with updates and newest feature releases

Presentations

Start Up
IPO
SPAC
M&A
Investor Day
Results
ESG
Credit
Investment Banking

Explore

Presentation Collections
Slide Collections

Company

Blog
Contact us
© 2021-2024 Slidebook.io